VX-702   Click here for help

GtoPdb Ligand ID: 6059

Synonyms: I14-1965 | VX 702 | VX702
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: VX-702 is a third generation Investigational oral p38 MAP kinase Inhibitor [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 102.31
Molecular weight 404.09
XLogP 3.14
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Fc1ccc(c(c1)F)c1nc(ccc1C(=O)N)N(c1c(F)cccc1F)C(=O)N
Isomeric SMILES Fc1ccc(c(c1)F)c1nc(ccc1C(=O)N)N(c1c(F)cccc1F)C(=O)N
InChI InChI=1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29)
No information available.
Summary of Clinical Use Click here for help
VX-702 has been tested in clinical trials as a therapy for rheumatiod arthritis. See for example NCT00205478 and NCT00395577, which are both completed Phase 2 trials. Further development of this compound appears to have been discontinued.